Correlation Between Home Depot and Cymabay Therapeu
Can any of the company-specific risk be diversified away by investing in both Home Depot and Cymabay Therapeu at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Home Depot and Cymabay Therapeu into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Home Depot and Cymabay Therapeu, you can compare the effects of market volatilities on Home Depot and Cymabay Therapeu and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Home Depot with a short position of Cymabay Therapeu. Check out your portfolio center. Please also check ongoing floating volatility patterns of Home Depot and Cymabay Therapeu.
Diversification Opportunities for Home Depot and Cymabay Therapeu
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Home and Cymabay is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Home Depot and Cymabay Therapeu in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cymabay Therapeu and Home Depot is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Home Depot are associated (or correlated) with Cymabay Therapeu. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cymabay Therapeu has no effect on the direction of Home Depot i.e., Home Depot and Cymabay Therapeu go up and down completely randomly.
Pair Corralation between Home Depot and Cymabay Therapeu
If you would invest 1,183 in Cymabay Therapeu on October 11, 2024 and sell it today you would earn a total of 0.00 from holding Cymabay Therapeu or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 4.76% |
Values | Daily Returns |
Home Depot vs. Cymabay Therapeu
Performance |
Timeline |
Home Depot |
Cymabay Therapeu |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Home Depot and Cymabay Therapeu Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Home Depot and Cymabay Therapeu
The main advantage of trading using opposite Home Depot and Cymabay Therapeu positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Home Depot position performs unexpectedly, Cymabay Therapeu can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cymabay Therapeu will offset losses from the drop in Cymabay Therapeu's long position.Home Depot vs. Morningstar Unconstrained Allocation | Home Depot vs. Thrivent High Yield | Home Depot vs. Via Renewables | Home Depot vs. T Rowe Price |
Cymabay Therapeu vs. Day One Biopharmaceuticals | Cymabay Therapeu vs. X4 Pharmaceuticals | Cymabay Therapeu vs. Inozyme Pharma | Cymabay Therapeu vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |